The company announced the signing of a Memorandum of Understanding between its subsidiary
"With these biosynthetic toad tryptamines, immense pressure will be lifted off toad populations for supplying therapeutic psychoactive compounds. Since there is no alternative source for these gland secretions, it put immense pressure on the wild toad population. These secretions are of help to improve the psychological health of humans. Works are also on to conserve the wild population of toads. As a result, one can understand this is a regenerative business model."
To provide a biosynthetic supply to these important therapeutic programs, in addition to stimulating needed research into the conservation status of wild populations, links our business success to improved outcomes for the toad. It is a regenerative business model" Dr.
The company also signed an MOU with
With this expansion, Lexston will be able to expand in the genetic and chemical analysis of natural products and psychedelics.
For more details, visit: https://lexston.ca
About
Lexston is passionate about people, plants, and the different processes that allow them to live in harmony and also heal accordingly. The company aims to make psychedelics available for all.
Disclaimer: This article is purely for informational purposes and is not a recommendation in any way to buy or sell stocks.
Media Contact
Company
Contact Person: Admin at Lexston
Email: admin@lexston.net
Country:
Website: lexston.ca
Source: www.abnewswire.com
.
(C) 2022 M2 COMMUNICATIONS, source